Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia
Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia
Active, not recruiting · NCT05445323 · Registry updated 2025-12-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia | Cardiomyopathies, Secondary, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Friedreich ataxia, Nutritional and Metabolic Diseases, Spinocerebellar Degenerations, brain disorder, cardiomyopathy, cardiovascular disorder, central nervous system disorder, cerebellar disorder, heart disorder, hereditary disease, inborn mitochondrial metabolism disorder, inherited neurodegenerative disorder, metabolic disease, nervous system disorder, neurodegenerative disease, spinal cord disorder | Active, not recruiting | Phase 1 / Phase 2 | 2025-12-23 | NCT05445323 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Lexeo Therapeutics | 7 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ataxia Center and HD Center of Excellence, University of California | Los Angeles | United States | 1 |
| Mayo Clinic | Rochester | United States | 664 |
| University of South Florida | Tampa | United States | 73 |